- Home
- AVTX vs ZENV Comparison
AVTX vs ZENV Comparison
Compare AVTX & ZENV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVTX
- ZENV
- Stock Information
- Founded
- AVTX 2011
- ZENV 2005
- Country
- AVTX United States
- ZENV Brazil
- Employees
- AVTX N/A
- ZENV N/A
- Industry
- AVTX Biotechnology: Pharmaceutical Preparations
- ZENV Computer Software: Prepackaged Software
- Sector
- AVTX Health Care
- ZENV Technology
- Exchange
- AVTX Nasdaq
- ZENV Nasdaq
- Market Cap
- AVTX 88.4M
- ZENV 80.2M
- IPO Year
- AVTX 2015
- ZENV 2021
- Fundamental
- Price
- AVTX $8.46
- ZENV $1.77
- Analyst Decision
- AVTX Strong Buy
- ZENV
- Analyst Count
- AVTX 7
- ZENV 0
- Target Price
- AVTX $34.33
- ZENV N/A
- AVG Volume (30 Days)
- AVTX 109.6K
- ZENV 104.3K
- Earning Date
- AVTX 05-12-2025
- ZENV 04-29-2025
- Dividend Yield
- AVTX N/A
- ZENV N/A
- EPS Growth
- AVTX N/A
- ZENV N/A
- EPS
- AVTX N/A
- ZENV N/A
- Revenue
- AVTX $441,000.00
- ZENV $173,594,726.00
- Revenue This Year
- AVTX N/A
- ZENV $28.66
- Revenue Next Year
- AVTX N/A
- ZENV $2.98
- P/E Ratio
- AVTX N/A
- ZENV N/A
- Revenue Growth
- AVTX N/A
- ZENV 23.49
- 52 Week Low
- AVTX $5.99
- ZENV $1.02
- 52 Week High
- AVTX $22.47
- ZENV $3.88
- Technical
- Relative Strength Index (RSI)
- AVTX 56.89
- ZENV 50.12
- Support Level
- AVTX $7.88
- ZENV $1.41
- Resistance Level
- AVTX $9.00
- ZENV $1.60
- Average True Range (ATR)
- AVTX 0.81
- ZENV 0.13
- MACD
- AVTX 0.12
- ZENV 0.05
- Stochastic Oscillator
- AVTX 54.41
- ZENV 52.17
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
About ZENV Zenvia Inc.
Zenvia Inc provides a platform that enables companies to create unique journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.